Clues to cancer drug’s deadly side effects could make it safer | Newswise: News for Journalists

X

Treatment with ISRIB, a small molecule inhibitor of the integrated stress response, is cardioprotective against ponatinib.

Credit: Image courtesy of the researchers.

Treatment with ISRIB, a small molecule inhibitor of the integrated stress response, is cardioprotective against ponatinib.

« Clues to cancer drug’s deadly side effects could make it safer

0.08911